Home » Topics » BioWorld Science

BioWorld Science
RSS

AIkido to use machine learning in development of novel broad-spectrum antivirals

Aug. 9, 2021

Targeting synaptogyrin-3 can ameliorate cognitive deficits

Aug. 9, 2021

Ichnos nominates ISB-1442 as its next clinical candidate

Aug. 9, 2021

ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011

Aug. 9, 2021

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

Aug. 9, 2021

Dongguan Hec New Drug Research and Development, Sunshine Lake Pharma identify HBV inhibitors

Aug. 9, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent PROTACs targeting cereblon

Aug. 9, 2021

Heparegenix identifies new MAPKK 4 inhibitors

Aug. 9, 2021

Discovery and preclinical characterization of a novel anti-SARS-CoV-2 MAb, MW-06

Aug. 9, 2021

Enrollment ongoing in first-in-human study of [68Ga]-FF58

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...